Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8819 |
High Similarity |
NPD2800 |
Approved |
0.8776 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8649 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD7819 |
Suspended |
0.8553 |
High Similarity |
NPD7411 |
Suspended |
0.8516 |
High Similarity |
NPD7075 |
Discontinued |
0.8442 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8397 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8378 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8377 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8367 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8313 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8311 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8299 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8299 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8278 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8278 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8278 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8269 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8247 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8243 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8231 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8217 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8205 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD920 |
Approved |
0.8138 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8092 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8082 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8082 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8041 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8041 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8027 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8026 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7922 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7901 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7867 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7867 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7867 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7867 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7862 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7834 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7831 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7815 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7755 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7746 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7744 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7744 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7738 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7711 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7682 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7669 |
Intermediate Similarity |
NPD919 |
Approved |
0.7655 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7654 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.764 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7588 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD2344 |
Approved |
0.758 |
Intermediate Similarity |
NPD5401 |
Approved |
0.756 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7545 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD7054 |
Approved |
0.75 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7415 |
Intermediate Similarity |
NPD3267 |
Approved |
0.74 |
Intermediate Similarity |
NPD411 |
Approved |
0.74 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7368 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7358 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7325 |
Intermediate Similarity |
NPD7003 |
Approved |
0.729 |
Intermediate Similarity |
NPD5406 |
Approved |
0.729 |
Intermediate Similarity |
NPD5408 |
Approved |
0.729 |
Intermediate Similarity |
NPD5405 |
Approved |
0.729 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7285 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7238 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7211 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7195 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5889 |
Approved |
0.719 |
Intermediate Similarity |
NPD943 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7184 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD4749 |
Approved |
0.716 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7095 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7088 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7088 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7044 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7025 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7025 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7018 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7007 |
Intermediate Similarity |
NPD17 |
Approved |
0.7006 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7006 |
Intermediate Similarity |
NPD8313 |
Approved |
0.6986 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6984 |
Remote Similarity |
NPD7584 |
Approved |
0.6957 |
Remote Similarity |
NPD2354 |
Approved |
0.6954 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD2403 |
Approved |
0.6935 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD1653 |
Approved |
0.6906 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6899 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD1778 |
Approved |
0.6883 |
Remote Similarity |
NPD7095 |
Approved |
0.6871 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD2296 |
Approved |
0.686 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6859 |
Remote Similarity |
NPD7585 |
Approved |
0.6857 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6857 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6855 |
Remote Similarity |
NPD4476 |
Approved |
0.6855 |
Remote Similarity |
NPD4477 |
Approved |
0.6842 |
Remote Similarity |
NPD1470 |
Approved |
0.6839 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6839 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6825 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6818 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6813 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6813 |
Remote Similarity |
NPD2353 |
Approved |
0.6806
|
Remote Similarity |
NPD7583 |
Approved |